Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva
Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva
Not yet recruiting · NCT07672782 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, carcinoma, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, squamous cell carcinoma, squamous cell neoplasm, vulva cancer, vulvar carcinoma, vulvar disease | Not yet recruiting | Phase 2 | 2026-06-29 | NCT07672782 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GOG Foundation | 38 |
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Levine Cancer Center | Charlotte | United States | 1 |